Latest News

Why Cleveland-Cliffs Stock Is Back in Focus After Q2 Results Cleveland-Cliffs (CLF) has drawn fresh attention after reporting second quarter and half year 2026 results, showing higher sales and a much smaller net loss compared with the same periods last year. See our latest analysis for Cleveland-Cliffs. The latest earnings update appears to have shifted sentiment, with Cleveland-Cliffs' share price jumping 15.98% on the day and 15.01% over the past week. However, the year to date share price...

Eli Lilly stock has returned roughly 4x over the past five years, yet the current valuation picture is split, with the intrinsic value estimate pointing to meaningful upside while the broader checks suggest the shares are not an obvious bargain. Eli Lilly has delivered a very large 5 year return of about 406.7%, which puts extra scrutiny on whether recent gains already reflect the key growth drivers. Expectations around new therapies in obesity, neuroscience and oncology can support...

Bombardier (TSX:BBD.B) is back in focus after securing a 10 year support agreement with Sweden’s defence agency for Global 6500 jets and adding new Global 6500 aircraft deliveries to South Korea’s Electronic Warfare program. See our latest analysis for Bombardier. Those defence wins land at a time when Bombardier’s momentum has been strong, with a 1 year total shareholder return of 125.59% and a 5 year total shareholder return of about 9x, alongside a 90 day share price return of 49.31%. If...

Intel’s latest earnings put a spotlight on how quickly money is moving toward AI hardware and the factories that support it. With Q2 revenue up 25% year on year, data centre and AI sales at $6.3b, and 2024 capital spending guidance lifted to $20b, investors are reconsidering which U.S. industrial and semiconductor related stocks might benefit or face tougher competition. This article looks at 3 stocks from a U.S. Industrial Reshoring and Semiconductor Manufacturing screener that appear...

Shin-Etsu PolymerLtd (TSE:7970) opened its Q1 2027 report with revenue of ¥30.6 billion and basic EPS of ¥30.04, setting the tone for how investors will be weighing growth against profitability trends this quarter. The company has seen revenue move from ¥28.0 billion and EPS of ¥38.65 in Q1 2026 to ¥30.6 billion and EPS of ¥30.04 in Q1 2027, giving a clear snapshot of how the top line and per share earnings have tracked over the past year. With a lower trailing net margin than a year ago, the...

Disco (TSE:6146) opened Q1 2027 with revenue of ¥114,308 million, basic EPS of ¥315.50 and net income of ¥34,221 million, setting the tone for how investors assess the latest quarter against its recent run. Over the last year the company has seen quarterly revenue move from ¥89,914 million in Q1 2026 to ¥114,308 million in Q1 2027, with basic EPS rising from ¥219.22 to ¥315.50 and trailing twelve month EPS reaching ¥1,346.09, which keeps attention squarely on how firmly margins are holding up...

Tractor Supply (NasdaqGS:TSCO) reported Q2 results that fell short of expectations and reduced its full year outlook. The company plans to close about 75 underperforming Petsense stores as part of a broader review of its pet specialty footprint. Management also outlined a slower pace of new store openings, citing ongoing adverse weather, weaker rural demand, and rising competition. Tractor Supply focuses on farm, ranch, and rural lifestyle customers, a segment that has faced pressure from...

Moderna stock has delivered a strong 84.8% return year to date, yet its low valuation score and expensive market multiples raise questions about how much of the story is already in the price. The 84.8% gain year to date signals that investors have sharply repriced Moderna as expectations around its pipeline and future revenue have shifted. Progress in areas such as the mRNA-4200 cancer program and the pending FDA decision on the mRNA-1010 flu vaccine can support growth hopes. At the same...

Oracle, ticker NYSE:ORCL, has secured a nearly $7b, 10 year software contract with the U.S. Department of Defense. The agreement will be used to modernize the Pentagon's defense technology stack and support cloud and AI adoption. The contract is expected to cover a wide range of critical military and intelligence organizations across the defense community. For investors tracking Oracle, this new Pentagon contract arrives after a challenging share price stretch. NYSE:ORCL last closed at...

With central banks keeping investors on edge over future rate moves and inflation risks tied to energy and global trade, cash generation and valuation discipline matter more than ever. Our Undervalued Stocks Based On Cash Flows screener focuses on companies where current prices sit below an internally assessed fair value using SWS DCF. It highlights situations where cash flow potential is not fully reflected in the market. This article walks through three stocks from that list and explains...

McKesson Corporation recently approved a quarterly dividend of US$0.94 per share, payable on October 1, 2026, to shareholders of record as of the September 1, 2026 ex-dividend date, marking its tenth consecutive year of dividend increases. This 15% dividend raise, alongside ongoing portfolio streamlining and oncology expansion, underlines management’s focus on steady cash returns while reshaping the business mix. We’ll now examine how McKesson’s higher dividend and portfolio reshaping may...

Sharplink (SBET) is on investors’ radar after recent trading placed its market value around US$1.23b, with the stock closing at US$6.00 and showing mixed return patterns across different timeframes. See our latest analysis for Sharplink. Recent trading in Sharplink highlights a sharp contrast between shorter term share price momentum and longer term outcomes. The 30 day share price return is up 20.85%, while the year to date share price return is down 38.08% and the 1 year total shareholder...

Allison Transmission Holdings has delivered a 225.8% total return over the past five years, yet its current share price still screens as cheap against an intrinsic value estimate from a Discounted Cash Flow (DCF) model and supporting market multiples. Recent defense contract wins add fresh cash flow expectations into the mix, raising the question of whether the market is still underpricing that future stream. A 225.8% return over five years points to a stock that has already rewarded long...

Huntington Bancshares recently reported its second-quarter 2026 results, with net interest income rising to US$2,052 million and net income to US$727 million, while basic earnings per share from continuing operations edged down to US$0.34. The quarter also saw higher net charge-offs of US$119 million, completion of the Cadence systems conversion, and a US$59 million share buyback alongside an unchanged US$0.155 common dividend, highlighting both credit cost pressure and management’s focus on...

Databricks and Microsoft have agreed to extend their collaboration into a decade-long partnership focused on Azure AI and data analytics. The deal includes deeper integration of Databricks' AI and analytics tools on Azure and adoption of Microsoft's custom chips. The partnership is positioned as a long-term development for Microsoft's cloud division as enterprises scale up AI projects on public cloud platforms. For investors following Microsoft, ticker NasdaqGS:MSFT, the expanded Databricks...

Renewed interest in Corteva (CTVA) is building as recent analyst commentary points to a strong record of topping earnings estimates and a positive Earnings ESP ahead of the upcoming quarterly report. See our latest analysis for Corteva. Corteva’s share price has moved to $88.78, with a 30 day share price return of 12.22% and a year to date share price return of 31.02%. The 5 year total shareholder return of 116.84% points to strong long term compounding and suggests momentum has been building...

BridgeBio Pharma recently announced that the FDA has accepted for filing its New Drug Application for encaleret to treat autosomal dominant hypocalcemia type 1, assigning a PDUFA target action date of May 8, 2027, and indicating no advisory committee meeting is currently planned. If approved, encaleret would be the first therapy specifically indicated for ADH1, targeting the underlying genetic cause and potentially obviating the need for chronic calcium and vitamin D supplementation in this...

Sinclair (SBGI) is back on investors’ radar after recent trading left the stock down 4% over the past month and 15% over the past 3 months, sharpening focus on its media-focused business model. See our latest analysis for Sinclair. At a share price of $13.37, Sinclair’s recent 7 day share price return of down 6.8% and year to date share price return of down 12.2% contrast with a 3 year total shareholder return of about 24%. This suggests recent momentum has faded even though longer term...

Bloom Energy stock has delivered a very large 3 year return, yet the valuation signals are split, with a discounted cash flow based intrinsic value estimate pointing to meaningful upside while market based multiples suggest the shares screen as expensive. That tension has grown more acute after recent news and contract wins around its fuel cell deployments for AI focused data centers. Bloom Energy has returned about 11.6x over the past 3 years, which puts more pressure on today’s buyers to...

With central banks weighing inflation risks, bond yields elevated and oil prices in focus, cash generation is back at the center of stock selection. In this kind of rate and inflation backdrop, many investors are rechecking whether they are overpaying for future growth and underpaying for existing cash flows. The Undervalued Stocks Based On Cash Flows screener looks for companies where the share price trades below an estimate of fair value using an SWS DCF valuation, highlighting potential...

Nike (NYSE:NKE) plans to shift all online sales in China to Nike-operated flagship stores on major platforms from 2027. The company intends to end online distribution through thousands of wholesale partners in the Greater China region. This reset focuses on tighter control of pricing, product selection, and brand presentation across Chinese ecommerce channels. Nike is a global sportswear company with a long-standing focus on direct-to-consumer channels, and China is one of its most...

Recent returns put Park National in focus Park National (PRK) is drawing investor attention after a run that includes a year to date total return of 19.8% and a past 3 months total return of 7.6%. These returns are prompting fresh questions about valuation and risk. See our latest analysis for Park National. Recent trading has cooled slightly, with the share price down 3.8% over the past week but still showing a 7.6% 90 day share price return and a 91.8% total shareholder return over five...

Caledonia Mining Corporation Plc recently reported second-quarter 2026 gold production of 17,360 ounces at its Blanket Mine in Zimbabwe, an 18% increase from the first quarter, alongside reaffirmed full-year production guidance of 72,000 to 76,500 ounces and steadily improving ore grades. At the same time, drilling at Blanket’s K-Pits target has revealed a new near-surface gold zone with oxide and deeper sulphide mineralisation, opening the possibility of a lower-cost heap leach operation...

After a sharp 21.9% gain over the past month, Thermo Fisher Scientific now sits in a more finely balanced spot on price. The Discounted Cash Flow (DCF) intrinsic value suggests the stock is roughly in line with fair value, while market based multiples lean more expensive. The 21.9% rise in the past month puts recent momentum front and center, which can leave less room for error if expectations later cool. Recent contract wins and product launches can support expectations for future cash...